Join
Live feed
·
FDARegulatoryvia Quantisnow
Opiant Pharmaceuticals Inc. logo

May 22, 2023 - FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose

ByQuantisnow·Wall Street's wire, on your screen.
OPNT· Opiant Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OPNT (Opiant Pharmaceuticals Inc.) and more on Quantisnow.